Traditional MedicareAdministrativeMedium impact
Senior Services News Vol. 5, No. 9
New Jersey Medicaid·NJ · Endocrinology, Oncology·Provider Notice
Effective date
Feb 1, 2002
We identified it
Jun 20, 2026
Summary
New Jersey's PAAD program now requires pharmacies to comply with Medicare Part B DMEPOS supplier requirements and submit EDI enrollment forms to continue participation. PAAD will act as billing agent for dually eligible Medicare/PAAD claims, requiring ICD-9 diagnosis codes on prescriptions for Medicare-covered drugs.
Action Required
Before February 1, 2002: New Jersey pharmacies participating in PAAD/Senior Gold programs must submit completed EDI enrollment forms to comply with Medicare Part B DMEPOS supplier requirements or face suspension. Pharmacies must obtain ICD-9 diagnosis codes on prescriptions for Medicare-covered drugs and contact First Health Services at 609-588-7146 when edit codes 444/423 appear. For insulin-dependent diabetics, add ZX modifier to ICD-9 codes; for non-insulin dependent diabetics, add KS modifier.